ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.85
0.00%
US Tech 100
21,018.40
0.18%
S&P 500
5,990.37
0.25%
US Dollar vs CAD
1.43341
-0.04%
Bitcoin
100,577.48
-1.67%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Celldex Therapeutics Inc (CLDX) Share Price

Celldex Therapeutics Inc

Celldex Therapeutics Inc (CLDX)

NASDAQ
26.58
-0.23
(-0.86%)
Closed January 06 3:00PM
Delayed by 15 minutes
27.20
0.62
( 2.33% )
Pre Market: 8:28AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
27.20
Bid
24.15
Ask
27.75
Volume
205
0.00 Day's Range 0.00
22.9291 52 Week Range 53.18
Market Cap
1.805B
Previous Close
26.58
Open
-
Last Trade
1
@
27.19
Last Trade Time
07:35:54
Financial Volume
-
VWAP
-
Average Volume (3m)
1,000,700
Shares Outstanding
66,344,236
Dividend Yield
-
PE Ratio
-12.47
Earnings Per Share (EPS)
-2.13
Revenue
6.88M
Net Profit
-141.43M

About Celldex Therapeutics Inc

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
www.celldex.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Celldex Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CLDX. The last closing price for Celldex Therapeutics was US$26.58. Over the last year, Celldex Therapeutics shares have traded in a share price range of US$ 22.9291 to US$ 53.18.

Celldex Therapeutics currently has 66,344,236 shares outstanding. The market capitalization of Celldex Therapeutics is US$1.76 billion. Celldex Therapeutics has a price to earnings ratio (PE ratio) of -12.47.

Ask ADVFN Intelligence (AI)

Celldex Therapeutics (CLDX) Options Flow Summary

CLDX Options Flow

Overall Flow

Bearish

Net Premium

-213k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

CLDX Latest News

More News

Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis

HAMPTON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis...

December 19 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

November 20 2024
Edgar (US Regulatory)

Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases

HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 1a study of CDX-622 in...

November 20 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 12 2024
Edgar (US Regulatory)

Celldex Therapeutics to Present at Upcoming Investor Conferences

HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:...

November 11 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.847.2555205047325.3627.17524.55102493526.34791171CS
40.642.4096385542226.5627.2323.9491668925.79445039CS
12-3.09-10.201386596230.2930.4822.9291100070026.47862981CS
26-8.73-24.297244642435.934722.929196936132.05979897CS
52-11.8-30.25641025643953.1822.929189333035.98178037CS
156-8.73-24.297244642435.9353.1819.8569255633.86293703CS
26024.59942.145593872.6157.21.576060327.03629611CS

CLDX - Frequently Asked Questions (FAQ)

What is the current Celldex Therapeutics share price?
The current share price of Celldex Therapeutics is US$ 27.20
How many Celldex Therapeutics shares are in issue?
Celldex Therapeutics has 66,344,236 shares in issue
What is the market cap of Celldex Therapeutics?
The market capitalisation of Celldex Therapeutics is USD 1.76B
What is the 1 year trading range for Celldex Therapeutics share price?
Celldex Therapeutics has traded in the range of US$ 22.9291 to US$ 53.18 during the past year
What is the PE ratio of Celldex Therapeutics?
The price to earnings ratio of Celldex Therapeutics is -12.47
What is the cash to sales ratio of Celldex Therapeutics?
The cash to sales ratio of Celldex Therapeutics is 256.32
What is the reporting currency for Celldex Therapeutics?
Celldex Therapeutics reports financial results in USD
What is the latest annual turnover for Celldex Therapeutics?
The latest annual turnover of Celldex Therapeutics is USD 6.88M
What is the latest annual profit for Celldex Therapeutics?
The latest annual profit of Celldex Therapeutics is USD -141.43M
What is the registered address of Celldex Therapeutics?
The registered address for Celldex Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Celldex Therapeutics website address?
The website address for Celldex Therapeutics is www.celldex.com
Which industry sector does Celldex Therapeutics operate in?
Celldex Therapeutics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 17.52
(0.00%)
73.73k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.28
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.41
(0.00%)
2.91k
AACGATA Creativity Global
US$ 0.9399
(0.00%)
56
AALAmerican Airlines Group Inc
US$ 17.52
(0.00%)
73.73k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.28
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.41
(0.00%)
2.91k
AACGATA Creativity Global
US$ 0.9399
(0.00%)
56
XTIAXTI Aerospace Inc
US$ 0.088
(0.00%)
698.09M
RIMEAlgorhythm Holdings Inc
US$ 0.1448
(0.00%)
192.75M
SVMHSRIVARU Holding Ltd
US$ 0.0463
(0.00%)
137.57M
CDTConduit Pharmaceuticals Inc
US$ 0.0723
(0.00%)
96.78M
CEROCERo Therapeutics Holdings Inc
US$ 0.0423
(0.00%)
77.33M

CLDX Discussion

View Posts
harry crumb harry crumb 20 hours ago
Been adding to the retirement shares here, positive news on the science an we go to 40+ that quick! $$$$
👍️0
harry crumb harry crumb 1 month ago
Shorts playing with fire here, watch what happens when the squeez begins, oh my 40's fast an furious $$$$$$
👍️0
harry crumb harry crumb 2 months ago
Tripling down here! This science will be a game changer. Looking at 70+ share an could be bought out. Let em take it down the dumbass', the squeeze will be epic here!!
👍️0
TechandBio TechandBio 2 months ago
Way overblown on the hair color change & neutropenia side effects from the trial should of waited a little bit longer will buy more they want to play mind games and bring it down the 52 week low. Great Team CASH to fund through phase 3 and a molecule that is next level.

Celldex ACAAI 12 Week CIndU Conference Call & Webcast
Oct 28, 2024 at 8:00 AM EDT
https://ir.celldex.com/static-files/86311fa1-d1e8-45b7-ad38-d557ff40c836


$CLDX
👍️0
harry crumb harry crumb 3 months ago
Added more
👍️0
harry crumb harry crumb 3 months ago
Yep, have patience. Legitimate company with sciences that may change the health care industry
👍️0
TechandBio TechandBio 3 months ago
just loaded another 12 pack.

$CLDX
👍️0
TechandBio TechandBio 3 months ago
Expect this one to double or triple from here!

$CLDX
👍️0
harry crumb harry crumb 3 months ago
Added
👍️0
TechandBio TechandBio 3 months ago
A few years ago CLDX was $4.00
Been my best year in biotech investing Viking, Summit and Capr.
$CLDX
👍️0
harry crumb harry crumb 3 months ago
Loaded more at 30.21-30.40
👍️0
harry crumb harry crumb 3 months ago
Nice buying afterhours
👍️0
harry crumb harry crumb 3 months ago
The stock market has been insanely crazy, companies doing well often get hit hard on good news for a period, then storm to the top, cldx released the news on their science and it is looking extremely well, so many things can happen but often enough news like this on a drug at some point will send the stock to new high’s, patience and happy trading
👍️0
harry crumb harry crumb 3 months ago
I doubt it, but could be wrong. We snatched up multiple lots and will hold long here
👍️0
TechandBio TechandBio 3 months ago
Loaded a nice stash under $30.00 yesterday!

$CLDX
👍️0
2020trader 2020trader 3 months ago
EXPECTING LOWER
👍️0
harry crumb harry crumb 3 months ago
This science may be worth the wait folks, ya gotta think big pharma has all eyes on it! $$$$$$$
👍️0
harry crumb harry crumb 3 months ago
Weeeee great time to add, easily see 40+ again, lets make money! $$$$$
👍️0
Monksdream Monksdream 4 months ago
CLDX range bound
👍️0
harry crumb harry crumb 5 months ago
Crushed on positive news!
👍️0
harry crumb harry crumb 5 months ago
Big run!never made it into the 20’s but we’l sit on what we own for a buyout later $$$$$
👍️0
harry crumb harry crumb 7 months ago
If this continues down into the 20’s we are tripling down, free shares anyway since the big explosion to 50’s
👍️0
harry crumb harry crumb 10 months ago
Indeed
👍️0
Monksdream Monksdream 10 months ago
CLDX new 52 week high
👍️0
harry crumb harry crumb 10 months ago
We shorted the offering for 2 days, in an out then long since
👍️0
Monksdream Monksdream 10 months ago
CLDX new 52 week high
👍️0
harry crumb harry crumb 10 months ago
That was way back, we went long but are out. Missed this pop
👍️0
fwb fwb 10 months ago
Did you SHORT CLDX back in NOV 2023?
If you did you loss your PANTS (SHORTS)
👍️0
harry crumb harry crumb 1 year ago
Burn cldx burn, another round of dilution, shorting this is money!
👍️0
harry crumb harry crumb 1 year ago
Timber lmao
👍️0
harry crumb harry crumb 1 year ago
Tomorrow this will be 24
👍️0
harry crumb harry crumb 1 year ago
Sold out the pump thank god. Short position now after this news of dilution, this company sure knows how to screw long investors. 25k short, lets take it to 20 now folks
👍️0
harry crumb harry crumb 1 year ago
Told everybody shorts are an still are in deep risk moving forward. Looking at a run to 44+ coming
👍️0
harry crumb harry crumb 1 year ago
Cldx will be bought out in due time imo $$$$$$$$ shorts continue to burn to ground
👍️0
harry crumb harry crumb 1 year ago
Burn shorts burn, this is going to be epic when it happens, buyout can happen anytime! $$$$$
👍️0
harry crumb harry crumb 1 year ago
I can’t wait to see the naked shorts fry like pigs when the buyout price is announced!40+ $$$$$!
👍️0
harry crumb harry crumb 1 year ago
Buying more
👍️0
harry crumb harry crumb 1 year ago
Buy it up shorts are gonna pay deeply, buyout ahead imo. $$$$$$
👍️0
harry crumb harry crumb 1 year ago
Loading again here
👍️0
harry crumb harry crumb 1 year ago
Buying opportunity, bought the dip at open, looking real good
👍️0
fwb fwb 2 years ago
COULD BE.
👍️0
harry crumb harry crumb 2 years ago
Could be a buyout coming
👍️0
harry crumb harry crumb 2 years ago
Another positive for cldx $$$$
👍️0
fwb fwb 2 years ago
This stock use to be called Avant Immunotherapeutics

Avant Immunotherapeutics to Merge with Celldex Therapeutics, Inc. in All-Stock Deal
👍️0
harry crumb harry crumb 2 years ago
Hey mr canes, how u been, gl this year
👍️0
harry crumb harry crumb 2 years ago
More wealth with this play, question is, what is brewing here, not many followers but flipping this has been easy money, all free shares here riding it onward for some epic news
👍️0
harry crumb harry crumb 2 years ago
Lmao, your alright. GL
👍️0
The Canes The Canes 2 years ago
Based on your imbecilic remarks I implore you seek counseling. Pointedly seek juvenile counseling. Now please go back to posting to yourself. I'm taking to my wife out to our favorite Michelin spot and a enjoying bottle of Dom Perignon. The 2003 Plenitude - 2 is special. Of course since you can't afford it you'll have to take my word for it. Have a cold Busch instead it's as close as you'll come to a woman. Get well!
👍️0
harry crumb harry crumb 2 years ago
Dont forget to put your dolls away, barbie might get mad at you.
👍️0
harry crumb harry crumb 2 years ago
Yur wife luvs me! Lmao little guy
👍️0

Your Recent History

NASDAQ
CLDX
Celldex Therapeutics
BIT
XAT1
Invesco At1 Capital Bond...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads